World experts from the medical and scientific community met in Berlin to celebrate and explore the current understanding of aspirin’s multifaceted role in modern Medicine. Read the full press release to view the conference overview video and register your interest to watch the conference lectures.
Release date: December 2017
The International Aspirin Foundation is delighted to announce that G.L. Pharma GmbH has joined its group of Supporters who are aligned with The Foundation’s aims of increasing awareness and medical research in aspirin.
Release date: December 2017
The 2017 winner, Dr Linxin Li, was selected for her ground breaking prospective population-based cohort study in patients with a first transient ischaemic attack, ischaemic stroke, or myocardial infarction treated with antiplatelet drugs (mainly aspirin based, without routine PPI use) after the event in the Oxford Vascular Study.
Release date: October 2017
Professor Peter Rothwell hands Professor Carlo Patrono the Chair of the Aspirin Foundation Scientific Advisory Board
Professor Carlo Patrono is delighted to take on the role of Chair of the Scientific Advisory Board (SAB) at the International Aspirin Foundation. Professor Patrono looks forward to further developing the Foundation as an instrument for a joint venture of the medical/scientific community and Industry in exploring aspirin’s role in disease prevention and treatment.
Release date: September 2017
The International Aspirin Foundation strengthens its Scientific Advisory Board and welcomes Dr John Chia
The International Aspirin Foundation is delighted and honoured to welcome Dr John WK Chia to its Scientific Advisory Board. Dr Chia is active in clinical trial research; and has developed and/or led numerous clinical trial studies– including immune check-point inhibitors, cancer vaccines, adoptive T cell, and small molecule targets for cancer.
Release date: July 2017
Clinicians and scientists from across the globe will meet at Charité – Berlin Museum of Medical History, Berlin on September 14th 2017 to celebrate 120 years since the synthesis of acetylsalicylic acid. Aspirin maybe relatively old in pharmaceutical terms but research regarding its many exciting indications and its role in disease prevention is new and expanding. The International Aspirin Foundation is delighted to be able to bring together world leaders in aspirin research and facilitate an in depth discussion of the important role aspirin has in the prevention and treatment of disease.
Release date: May 2017
The International Aspirin Foundation is delighted and honoured to welcome Professor Lina Badimon to its Scientific Advisory Board. Professor Badimon’s research activities focus on thrombosis and hemostasis, atherosclerosis, lipids and inflammation.
Professor Badimon is the Director of the Cardiovascular Research Center in Barcelona (CSIC‐ICCC) in the Hospital Santa Creu and San Pau, Director of the Cardiovascular Research Chair of the Autonomous University of Barcelona and Director of the UNESCO Chair in Biomedical Sciences Training and Research.
Release date: Feb 2017
The International Aspirin Foundation expands its reach to China and welcomes Professor Ge to the Scientific Advisory Board
The International Aspirin Foundation is delighted and honoured to welcome Professor Junbo Ge to its Scientific Advisory Board.
Professor Ge is a member of Chinese Academy of Sciences, professor and doctoral supervisor and works as the director for Shanghai Institute of Cardiovascular Disease and the Center for Stem Cells and Tissue Engineering.
Release date: Sept 2016
Podcast from BBC Radio 4 Inside Health Programme, first broadcast on 4 October 2016. Dr Mark Porter interviews the International Aspirin Foundation Chairman, Prof Peter Rothwell, on the subject of Mini-Strokes.
Three world-class professors, Nancy Cook, Michael Gaziano and Julie Buring, From Boston were today, 30th September 2016, announced as the winners of the 2016 International Apirin Foundation Senior Science Award for their wok on the two largest ever randomised trials of Aspirin. You can also read the announcement on the Harvard School of Public Health website (this opens in a new window)
Release date: Sept 2016
This report provides a relatively concise and current overview of activity, which reflects the depth of expertise and knowledge of the members of the Scientific Advisory Board, from both geographical and scientific areas.
Release date: August 2016
Rothwell PM, Algra A, Chen z, Diener HC, Norrving B and Mehta Z. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: tome-course analysis of randomised trials.
Release date: May 2016
DISCLAIMER (updated November 2016)
- The information, views and opinions expressed on the International Aspirin Foundation website are not endorsed or approved by members of the Scientific Advisory Board unless otherwise stated
- The Information section on the website is compiled using current published information at the time of writing and whilst every effort has been made to avoid errors, professional clinical judgement is required to interpret the information given. The information given is referenced clearly for further analysis as required
- Every effort is made by the International Aspirin Foundation to see that no misleading or inaccurate data, statement or opinion appear on the website, the International Aspirin Foundation cannot be held responsible for any errors or for any consequences arising from the use of the information contained on the website
- The International Aspirin Foundation, its associates and the Scientific Advisory Board accept no liability whatsoever for the consequences of any such inaccurate or misleading data, information, opinion or statement
- Any information involving drug usage, should only be followed in conjunction with the drug manufacturer’s own published literature in their own country
- Medical sciences evolve on a continual basis and therefore independent verification of the website content should be made
- The information, views, opinions and any other material provided on this website should not be relied upon as a substitute to professional medical advice in relation to any medical condition. The International Aspirin Foundation, its associates and The Scientific Advisory Board accept no liability whatsoever for any consequences arising from any reliance placed on such information, views, opinions and other materials in lieu of professional medical advice
- The Aspirin Foundation activities are supported through a sponsorship of Bayer AG, Berlin, Germany. The sponsor does not have any influence over the operations of the International Aspirin Foundation activities.